Heparin-induced thrombocytopenia: present and future

被引:0
作者
Adam Cuker
机构
[1] University of Pennsylvania,Department of Medicine
[2] University of Pennsylvania,Department of Pathology and Laboratory Medicine
[3] Penn Comprehensive Hemophilia and Thrombosis Program,undefined
来源
Journal of Thrombosis and Thrombolysis | 2011年 / 31卷
关键词
Heparin-induced thrombocytopenia; HIT; Epidemiology; Pathophysiology; Diagnosis; Management;
D O I
暂无
中图分类号
学科分类号
摘要
Heparin-induced thrombocytopenia (HIT) is a prothrombotic and potentially devastating complication of heparin therapy due to formation of platelet-activating antibodies against complexes of platelet factor 4 and heparin. Over the last several decades, great advances in our understanding of HIT have elevated a once enigmatic syndrome, the mere existence of which was doubted by the medical community, to a well-characterized disorder. Nevertheless, critical questions remain unanswered. The objective of this review is to examine our current understanding of the epidemiology, pathophysiology, diagnosis, and management of HIT and to highlight areas of future inquiry.
引用
收藏
页码:353 / 366
页数:13
相关论文
共 733 条
  • [1] Visentin GP(1994)Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells J Clin Invest 93 81-88
  • [2] Ford SE(1994)Heparin-associated thrombocytopenia: isolation of the antibody and characterization of a multimolecular PF4-heparin complex as the major antigen Thromb Haemost 71 247-251
  • [3] Scott JP(1994)Immunoglobulin G from patients with heparin-induced thrombocytopenia binds to a complex of heparin and platelet factor 4 Blood 83 3232-3239
  • [4] Aster RH(2005)Risk for heparin-induced thrombocytopenia with unfractionated and low-molecular-weight heparin thromboprophylaxis: a meta-analysis Blood 106 2710-2715
  • [5] Greinacher A(1995)Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin N Engl J Med 332 1330-1335
  • [6] Potzsch B(2003)The incidence of heparin-induced thrombocytopenia in hospitalized medical patients treated with subcutaneous unfractionated heparin: a prospective cohort study Blood 101 2955-2999
  • [7] Amiral J(2006)Gender imbalance and risk factors interactions in heparin-induced thrombocytopenia Blood 108 2937-2941
  • [8] Dummel V(2007)Heparin-induced thrombocytopenia associated with fondaparinux N Eng J Med 356 2653-2655
  • [9] Eichner A(2008)Fondaparinux-related thrombocytopenia in a previous low-molecular-weight heparin (LMWH)-induced heparin-induced thrombocytopenia (HIT) Thromb Haemost 99 779-781
  • [10] Mueller-Eckhardt C(2010)Fondaparinux thromboprophylaxis-associated heparin-induced thrombocytopenia syndrome complicated by arterial thrombotic stroke Thromb Haemost 104 1071-1072